Tamoxifen has reduced breast cancer rates 'by a third'
12/12/2014
A well-established and effective treatment for breast cancer, tamoxifen has now been shown to have long-term preventive benefits for women at high risk.
Protein inhibitor makes toughest breast cancer cell susceptible to chemotherapy
12/12/2014
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments.
Some ovarian and breast cancer patients may benefit from manipulation of a non-coding microRNA
12/12/2014
A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.
Some ovarian and breast cancer patients may benefit from manipulation of a non-coding microRNA
12/12/2014
A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.
New targeted drugs could treat drug-resistant skin cancer
12/11/2014
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports.
Getting antibodies into shape to fight cancer
12/11/2014
Scientists at the University of Southampton have found that the precise shape of an antibody makes a big difference to how it can stimulate the body's immune system to fight cancer, paving the way...
Gilead Sciences, Inc. has announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and the safety profile for...
On 8th December 2014, the Scottish Medicines Consortium accepted for use within NHS Scotland Alimta (pemetrexed) monotherapy for the maintenance treatment of locally advanced or metastatic...
Improved treatment for dermatitis in cancer patients
12/11/2014
Researchers have shown how a topical steroid cream frequently used to treat common skin conditions, can be used to improve dermatitis in cancer patients.
Castle Biosciences Inc. has announced the publication of study results that assess current clinical practices for uveal melanoma (UM) and demonstrate the impact of molecular prognostic testing on...